Transcript: Scott Gottlieb on "Face the Nation"

The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired Sunday, June 7, 2020, on "Face the Nation."

• Jun 7, 2020

Gottlieb warns of uptick in coronavirus infections after protests

Tens of thousands of Americans have protested the death of George Floyd in cities from coast to coast.

• May 31, 2020

Transcript: Scott Gottlieb on "Face the Nation"

The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired Sunday, May 31, 2020, on "Face the Nation."

• May 31, 2020

Scott Gottlieb warns coronavirus "isn't contained yet"

Gottlieb said Americans need to "define a new normal" as the coronavirus continues to threaten communities.

• May 24, 2020

Transcript: Scott Gottlieb on "Face the Nation"

The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired Sunday, May 24, 2020, on "Face the Nation."

• May 24, 2020

New warnings about sleep medications

Millions of Americans suffer from insomnia and take prescription sleep aids to get them through the night, but the possible side effects can be serious. Now the FDA has issued the strongest warning so far. CBS News' Meg Oliver reports.

• May 1, 2019
• 01:36

Breaking down the science of sunscreen

A study in JAMA analyzed blood samples of 24 people who used sunscreen four times a day, for four days. Researchers found levels of four chemical ingredients that exceed the FDA’s recommended limits. The authors caution that the health effects, if any, are unknown, and people should continue to apply sunscreen to protect against skin cancer. As we continue our coverage of Skin Cancer Awareness Month, Dr. Tara Narula joins "CBS This Morning" to separate sunscreen fact from fiction.

• May 7, 2019
• 02:53

Cows linked to E. coli lettuce outbreaks that sickened nearly 200

FDA ties feces from grazing cattle in California's Salinas Valley to food-borne illness from romaine lettuce leaves.

• May 22, 2020

FDA to improve access to experimental cancer drugs

Thousands of gravely ill cancer patients each year seek "compassionate use" access to treatments that are not yet on the market, but have shown some promise in early testing and aren't available to them through a study. The government wants to make that access easier and give more heft to the requests.

• Jun 3, 2019
• 01:01

E-cig bans: Are they legal? Are they safe?

San Francisco will become the first U.S. city to ban e-cigarette sales, after a unanimous vote by its board of supervisors on Tuesday. The mayor has indicated she will sign the measure. E-cigarettes have not been approved by the FDA, and the agency has called e-cigarette use by young people an “epidemic.” CBS News medical contributor Dr. Tara Narula and CBS News legal analyst Rikki Klieman join “CBS This Morning” to discuss the safety and legality of the ban.

• Jun 26, 2019
• 05:08

Pharma rep exposes opioid lollipop marketing

A pharmaceutical salesman went undercover to expose his company for illegally marketing an addictive cancer drug. Bruce Boise was tasked with promoting Actiq, a pain-killing lollipop containing the opioid fentanyl, for treatments not approved by the FDA. “Whistleblower” host Alex Ferrer joins “CBS This Morning” to discuss the show’s season finale.

• Jun 28, 2019
• 04:07

Dog food recall issued

The FDA is investigating a possible link between certain types of dog food and an increased risk of canine heart disease. The agency named 16 brands that were fed to more than 500 pets that developed heart disease.

• Jun 28, 2019
• 00:20

FDA launches anti-vaping ads

The Food and Drug administration is launching its first TV ads to fight vaping by teenagers. The FDA’s nearly $60 million initiative, called “The Real Cost,” includes new commercials featuring street magician Julius Dein, who uses tricks to educate teens on the risks of e-cigarettes. "CBS This Morning" consumer investigative national correspondent Anna Werner and CBS News medical contributor Tara Narula discuss the initiative.

• Jul 23, 2019
• 06:05

Breast implant recipient on cancer diagnosis

A major producer of breast implants is stopping the sale and distribution of their textured products, amid growing links to a rare and deadly cancer. The FDA requested the recall from Allergan after a "significant increase" in cases of a particular lymphoma. The FDA says the risk of lymphoma with Allergan's Biocell textured implants is approximately six times that of other manufacturers who are marketing in the U.S. Anna Werner reports.

• Jul 25, 2019
• 03:50

FDA wants new warning labels for cigaretes

Smokers would have a hard time overlooking the graphic images displayed on cigarette packages if federal health officials have their way. Illustrations of cancerous neck tumors, feet with amputated toes and diseased lungs are among the 13 new warnings that would be on cigarettes under a proposal. CBS News' Nikole Killion reports.

• Aug 15, 2019
• 01:48

Doctor warns about dangers of vaping

Federal health officials are investigating a sharp increase in serious lung illnesses that may be linked to vaping. Dr. Janette Nesheiwat joins CBSN to talk about the potential health risks.

• Aug 23, 2019
• 05:46

FDA sends warning letter to Juul Labs

Federal health authorities say vaping giant Juul Labs illegally pitched its electronic cigarettes as a safer alternative to smoking, including in a presentation at schools. The FDA on Monday issued a stern warning letter to the company, flagging claims by Juul including that its products are "much safer than cigarettes."

• Sep 9, 2019
• 00:48

The problem with Trump's e-cig crackdown

President Trump says a ban on most flavored vaping products is the right response to what health officials call an "epidemic" of e-cigarette use by teenagers. A recent jump in illnesses linked to vaping has grabbed the attention of lawmakers, regulators, and parents, including the president and first lady. But CBS News has learned any real crackdown is likely a long way off. It will take weeks for the FDA to release its final rule -- and even then, companies have time to respond. Paula Reid reports.

• Sep 12, 2019
• 03:04

Consumers decry flavored vaping products ban

Market research shows 22 million adults in the U.S. use e-cigarettes. On Wednesday, President Trump called for a ban on most flavored vaping products. But some consumers, who vape instead of smoking traditional cigarettes, say they deserve the right to choose flavored products because they're legally old enough. Meanwhile, some business owners worry that Trump's suggested ban will cripple sales. Janet Shamlian reports.

• Sep 12, 2019
• 02:22

Is vaping actually safer than smoking?

The White House is moving to curb the vaping epidemic in America that's linked to at least six recent deaths. A new initiative would ban most flavored e-cigarettes, allowing only tobacco flavor. Cases of possible vaping- related illnesses have been reported in at least 36 states, including Hawaii, Idaho, and Washington, which just reported their first cases this week. Dr. David Agus joins "CBS This Morning" to discuss why we still don't know the full health impact of e-cigarettes and the challenges of regulating them.

• Sep 12, 2019
• 04:50

FDA finds cancer-causing chemical Zantac

Small amounts of a cancer-causing chemical have been found in the popular heartburn medication Zantac, as well is in generic forms of the drug, known as Ranitidine. The FDA is not issuing a recall and says patients can continue taking the medication. Zantac's maker says it takes patient safety seriously and is committed to working with the FDA. Dr. David Agus joins "CBS This Morning: Saturday" to discuss what consumers need to know.

• Sep 14, 2019
• 01:49

Novartis halts distribution of generic heartburn medication

The maker of a generic version of Zantac is halting distribution. It comes after an FDA warning about a possible cancer-causing chemical found in Zantac and related heartburn medications. Dr. Jon LaPook explains.

• Sep 18, 2019
• 01:22

Distribution of generic Zantac halted

A version of a popular heartburn medicine is now on hold. There are concerns that the generic version of the drug known as Zantac may cause cancer. Novartis stopped the distribution of its prescription version as a precaution. The move comes after the FDA announced on Friday that it may contain NDMA, a probable carcinogen. Dr. Tara Narula joins “CBS This Morning” to discuss what consumers should know.

• Sep 19, 2019
• 03:00

U.S. vaping-related deaths now at 8

More than 500 people have been diagnosed with vaping-related breathing illnesses, but the cause remains unknown, U.S. health officials said Thursday. An eighth death was also reported in Missouri on Thursday. CBS News' Meg Oliver reports.

• Sep 19, 2019
• 01:23

FDA opens criminal probe into vaping illness

Eight deaths in the U.S. are now blamed on vaping, with the latest happening in Missouri. The Food and Drug Administration has revealed a criminal investigation of vaping-related illnesses. The CDC reports at least 530 confirmed and probable cases. Most of them involve vaping with THC, the psychoactive ingredient in marijuana, or both THC and nicotine. A bipartisan group in Congress is working with parents to keep teenagers away from e-cigarettes, while accusing the vaping industry of marketing to kids. Tony Dokoupil reports.

• Sep 20, 2019
• 02:46

Show More